Reporting antimicrobial susceptibilities and phenotypes of resistance to vancomycin in vancomycin-resistant Enterococcus spp. clinical isolates: A nationwide proficiency study

被引:0
|
作者
Fernandez-Cuenca, Felipe [1 ,2 ,3 ]
Lopez-Hernandez, Inmaculada [1 ,2 ,3 ]
Cercenado, Emilia [4 ,5 ,6 ]
Conejo, Maria Carmen [7 ]
Tormo, Nuria [8 ,9 ]
Gimeno, Concepcion [8 ,9 ]
Pascual, Alvaro [1 ,2 ,3 ,7 ]
机构
[1] Hosp Univ Virgen Macarena, Unidad Clin Enfermedades Infecciosas & Microbiol C, Seville, Spain
[2] Univ Seville, Hosp Univ Virgen Macarena, Inst Biomed Sevilla IBIs, CSIC, Seville, Spain
[3] Inst Salud Carlos III, Spanish Network Res Infect Dis REIPI RD16 0016, Madrid, Spain
[4] Hosp Gen Univ Gregorio Maranon, Serv Microbiol & Enfermedades Infecciosas, Madrid, Spain
[5] Univ Complutense, Fac Med, Dept Med, Madrid, Spain
[6] Ctr Invest Biomed Red Enfermedades Resp, CIBERES, CB06 06 0058, Madrid, Spain
[7] Univ Seville, Dept Microbiol, Seville, Spain
[8] Hosp Gen Valencia, Serv Microbiol, Valencia, Spain
[9] Spanish Soc Clin Microbiol & Infect Dis SEIMC, Qual Control Programme CCS, Valencia, Spain
来源
关键词
Enterococcus spp; Quality control; Vancomycin resistance; Antimicrobial susceptibility; National multicenter study; TEICOPLANIN RESISTANCE; VITEK; 2; EPIDEMIOLOGY; INFECTIONS;
D O I
10.1016/j.eimc.2021.11.011
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: The ability of Spanish microbiology laboratories to (a) determine antimicrobial suscepti-bility (AS), and (b) correctly detect the vancomycin resistance (VR) phenotype in vancomycin-resistant Enterococcus spp. (VRE) was evaluated.Methods: Three VRE isolates representing the VanA (E. faecium), VanB (E. faecium) and VanC (E. gallinarum) VR phenotypes were sent to 52 laboratories, which were asked for: (a) AS method used; (b) MICs of ampicillin, imipenem, vancomycin, teicoplanin, linezolid, daptomycin, ciprofloxacin, levofloxacin and quinupristin-dalfopristin, and high-level resistance to gentamicin and streptomycin; (c) VR phenotype.Results: (a) The most frequently used system was MicroScan; (b) according to the system, the highest percentage of discrepant MICs was found with gradient strips (21.3%). By antimicrobial, the high-est rates of discrepant MICs ranged 16.7% (imipenem) to 0.7% (linezolid). No discrepant MICs were obtained with daptomycin or levofloxacin. Mayor errors (MEs) occurred with linezolid (1.1%/EUCAST) and ciprofloxacin (5.0%/CLSI), and very major errors (VMEs) with vancomycin (27.1%/EUCAST and 33.3%/CLSI) and teicoplanin (5.7%/EUCAST and 2.3%/CLSI). For linezolid, ciprofloxacin, and vancomycin, discrepant MICs were responsible for these errors, while for teicoplanin, errors were due to a misassignment of the clinical category. An unacceptable high percentage of VMEs was obtained using gradient strips (14.8%), especially with vancomycin, teicoplanin and daptomycin; (c) 86.4% of the centers identified VanA and VanB phenotypes correctly, and 95.0% the VanC phenotype.Conclusion: Most Spanish microbiology laboratories can reliably determine AS in VRE, but there is a significant percentage of inadequate interpretations (warning of false susceptibility) for teicoplanin in isolates with the VanB phenotype.& COPY; 2021 Sociedad Espanola de Enfermedades Infecciosas y Microbiologi & PRIME;a Cli & PRIME;nica. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:335 / 341
页数:7
相关论文
共 50 条
  • [32] First cluster of vancomycin-resistant Enterococcus faecalis isolates in Cyprus
    Daikos, GL
    Triantafyllopoulou, P
    Syriopoulou, V
    Bakatzouni-Pieridou, D
    Kontou, M
    Theodoulou, M
    Tofas, P
    Petrikkos, G
    CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (03) : 232 - 234
  • [33] Activity of vancomycin combined with linezolid against clinical vancomycin-resistant Enterococcus strains
    Aktas, Gulseren
    ARCHIVES OF MEDICAL SCIENCE, 2023, 19 (01) : 189 - 193
  • [34] In Vitro Susceptibilities and Molecular Analysis of Vancomycin-Intermediate and Vancomycin-Resistant Staphylococcus aureus Isolates
    Saravolatz, Louis D.
    Pawlak, Joan
    Johnson, Leonard B.
    CLINICAL INFECTIOUS DISEASES, 2012, 55 (04) : 582 - 586
  • [35] Vancomycin-resistant Enterococcus spp. isolated from wastewater and chicken feces in the United States
    Harwood, VJ
    Brownell, M
    Perusek, W
    Whitlock, JE
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2001, 67 (10) : 4930 - 4933
  • [36] Occurrence of vancomycin-resistant and -susceptible Enterococcus spp. in reclaimed water used for spray irrigation
    Carey, Stephanie Ann
    Goldstein, Rachel E. Rosenberg
    Gibbs, Shawn G.
    Claye, Emma
    He, Xin
    Sapkota, Amy R.
    ENVIRONMENTAL RESEARCH, 2016, 147 : 350 - 355
  • [37] Molecular characterization of vancomycin-resistant Enterococcus spp. clinical isolates recovered from hospitalized patients among several medical institutions in China
    Sun, Hongli
    Wang, Hui
    Xu, Yingchun
    Jones, Ronald N.
    Costello, Andrew J.
    Liu, Yali
    Li, Gang
    Chen, Minjun
    Mendes, Rodrigo E.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2012, 74 (04) : 399 - 403
  • [38] Molecular and clinical epidemiology of vancomycin-resistant Enterococcus faecalis
    Oprea, SF
    Zaidi, N
    Donabedian, SM
    Balasubramaniam, M
    Hershberger, E
    Zervos, MJ
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (04) : 626 - 630
  • [39] Clinical Outcomes of Daptomycin for Vancomycin-resistant Enterococcus Bacteremia
    Moise, Pamela A.
    Sakoulas, George
    McKinnell, James A.
    Lamp, Kenneth C.
    DePestel, Daryl D.
    Yoon, Min J.
    Reyes, Katherine
    Zervos, Marcus J.
    CLINICAL THERAPEUTICS, 2015, 37 (07) : 1443 - 1453
  • [40] Clinical isolation of vancomycin-resistant Enterococcus faecalis in Taiwan
    Ben, RJ
    Lu, JJ
    Young, TG
    Chi, WM
    Wang, CC
    Chu, ML
    Wang, JC
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 1996, 95 (12) : 946 - 949